Oral hypoglycemic agents could also be used in patients with burnout syndrome, in which the “disappearance” of DM is almost always observed because of important homeostatic changes related to diet restrictions, catabolism, weight loss and greater circulation of endogenous insulin. This evidence concerns the gene INS and diabetes mellitus.